Groundbreaking: First-Ever HCC RAF Score Accessible Through REST API
First-Ever HCC RAF Score Accessible Through REST API
Check Now
Image depicting the concept of elevating provider support and enhancing concurrent coding for risk adjustment in healthcare.
Elevate Provider Support:
Enhance Your Concurrent Coding
for Risk Adjustment
Check Now

ICD-10-CM Diagnosis Code R68.89

Effective Date: 10/01/2015 To 09/30/2025

Other general symptoms and signs

CMS-HCC-V24 CMS-HCC-V28 RxHCC Age Gender Maternity Acute or Chronic MCC
-- -- -- -- -- -- Acute No
Back-references to R68.89
  • Abiotrophy R68.89
  • Abnormal, abnormality, abnormalities see also Anomaly
    • clinical findings NEC R68.89
    • Abulia R68.89
    • Autodigestion R68.89
    • Autointoxication R68.89
    • Autotoxemia R68.89
    • Congestion, congestive
      • general R68.89
        • viscera R68.89
        • Decrease(d)
          • functional activity R68.89
          • Depression(acute) (mental) F32.A
            • functional activity R68.89
            • Dysfunction
              • physiological NEC R68.89
              • Fugue R68.89
              • Hemiatrophy R68.89
              • Herxheimer's reaction R68.89
              • Hyperemia(acute) (passive) R68.89
              • Infirmity R68.89
              • Large
                • stature R68.89
                • Necrobiosis R68.89
                • Reaction see also Disorder
                  • Herxheimer's R68.89
                  • Rigors R68.89
                  • Symptoms NEC R68.89
                  • Toxemia R68.89
                    • fatigue R68.89
                      • stasis R68.89
                      • Related Medications for R68.89
                        • acetaminophen, acetylsalicylic acid, atropine, buprenorphine, butorphanol, chlordiazepoxide, desonide, dexamethasone, fluocinonide, fluoxetine, glyceryl trinitrate, guaifenesin, hydrocortisone, hydroxyzine, levonorgestrel, methenamine, methylene blue, naloxone, naltrexone, nefopam, neomycin, nicotine, orphenadrine, phenazopyridine, phenylephrine, polymyxin b, prednisolone, scopolamine, timolol, triamcinolone, apraclonidine, lofexidine, phenyl salicylate, latanoprost, loteprednol etabonate, dorzolamide, duloxetine, zaleplon, fexofenadine, brimonidine, hyoscyamine, brinzolamide, sodium phosphate, monobasic

                        Chapter, Section and Diagnosis Prefix for R68.89
                          R00-R99 :

                          Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

                          R50-R69 :

                          General symptoms and signs

                          R68 :

                          Other general symptoms and signs